We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

91 hedge funds and large institutions have $881M invested in Heron Therapeutics in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $12.4M | Put options by funds: $7.25M

70% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 23

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

4% more capital invested

Capital invested by funds: $848M → $881M (+$33.2M)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

1% less funds holding

Funds holding: 92 → 91 (-1)

Holders
91
Holders Change
-1
Holders Change %
-1.09%
% of All Funds
2.43%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
12
Increased
39
Reduced
23
Closed
13
Calls
$12.4M
Puts
$7.25M
Net Calls
+$5.17M
Net Calls Change
-$2.19M

Top Buyers

1
KCM
Kingdon Capital Management
New York
+$33.1M
2
BC
Broadfin Capital
New York
+$29.7M
3
HCMT
Highland Capital Management (Texas)
Texas
+$12.1M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$7.75M
5
RI
RTW Investments
New York
+$7.18M

Top Sellers

1
TCM
Tekla Capital Management
Massachusetts
-$8.89M
2
Brown Advisory
Brown Advisory
Maryland
-$5.56M
3
JP Morgan Chase
JP Morgan Chase
New York
-$5.04M
4
Citadel Advisors
Citadel Advisors
Florida
-$3.96M
5
UBS Group
UBS Group
Switzerland
-$3.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
LOAMU
26
Lombard Odier Asset Management (USA)
New York
$3.02M +$3.25M +175,000 New
Allianz Asset Management
27
Allianz Asset Management
Germany
$2.88M -$871K -46,922 -22%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$2.83M +$927K +49,963 +44%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.58M +$36.1K +1,946 +1%
Charles Schwab
30
Charles Schwab
California
$2.18M +$269K +14,500 +13%
BIM
31
BlackRock Investment Management
Delaware
$2.13M +$7.25K +391 +0.3%
Deutsche Bank
32
Deutsche Bank
Germany
$1.69M -$849K -45,741 -32%
GC
33
Guggenheim Capital
Illinois
$1.6M -$105K -5,652 -6%
Morgan Stanley
34
Morgan Stanley
New York
$1.45M +$1.14M +61,210 +268%
FAM
35
Fred Alger Management
New York
$1.41M -$338K -18,232 -18%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$1.16M +$13K +700 +1%
JP Morgan Chase
37
JP Morgan Chase
New York
$1.12M -$5.04M -271,796 -81%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.07M -$79.8K -4,300 -6%
CS
39
Candriam SCA
Luxembourg
$1.03M +$1.11M +60,000 New
BGIM
40
Brandywine Global Investment Management
Pennsylvania
$1.02M -$6.55K -353 -0.6%
GH
41
GAM Holding
Switzerland
$1.02M -$1.1M -59,100 -50%
PIM
42
Partner Investment Management
California
$969K +$148K +7,979 +17%
TA
43
Teachers Advisors
New York
$964K – – –
Swiss National Bank
44
Swiss National Bank
Switzerland
$894K – – –
AllianceBernstein
45
AllianceBernstein
Tennessee
$839K +$24.1K +1,300 +3%
CS
46
Credit Suisse
Switzerland
$810K -$166K -8,962 -16%
TI
47
Turner Investments
Pennsylvania
$782K -$950K -51,180 -53%
Bank of America
48
Bank of America
North Carolina
$769K +$65.2K +3,513 +9%
Goldman Sachs
49
Goldman Sachs
New York
$652K +$546K +29,404 +350%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$611K +$4.92K +265 +0.8%
1
2
3 4 5

HRTX Hedge Fund Activity: Q3 2016 in Review

91 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2016, worth a combined $881M — up 3.9% from $848M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HRTX and 12 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 39 added.

The largest buyer was Kingdon Capital Management, adding an estimated $33.1M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $8.89M sold.

  • 91 institutional investors held Heron Therapeutics (HRTX) as of Q3 2016, down from 92 in Q2 2016.
  • Funds reported $881M of Heron Therapeutics stock for Q3 2016, up 3.9% quarter-over-quarter.
  • 12 funds opened new Heron Therapeutics positions in Q3 2016 and 13 closed out, a net change of -1 holder.
  • The largest Heron Therapeutics buyer in Q3 2016 was Kingdon Capital Management, an estimated $33.1M added.
  • The largest Heron Therapeutics seller in Q3 2016 was Tekla Capital Management, an estimated $8.89M sold.

Based on aggregated 13F filings for Q3 2016.